RE:VMD's Growth Initiatives: Organic & Inorganic (Acquisitions)All these facts below hurt besttobe alias and his agenda against VMD.
Besttobe alias, the resident disgruntled employee, created his alias in 2019 and he has posted numerous negative messages on VMD's board over the last couple of years.
In his numerous messages,
besttobe alias has twisted the truth multiple times and/or he has made highly inaccurate remarks or he has posted outright lies. Pathetic.
stockfy wrote:
VMD's stock has overreacted lately and it's technically oversold. Technicals aside, VMD has been working on many growth initiatives, both organic and inorganic according to the CEO and COO. Its pristine balance sheet does allow it.
Visit Seeking Alpha and read carefully the latest Conference Call.
VMD said it clearly that the worst is behind us and business has almost returned to pre-pandemic levels.
See some key excerpts about the upcoming growth and the growth initiatives that VND is working on:
"The first quarter will very likely be the quarter where things began to reopen from the COVID-19 pandemic and I am once again proud of our ability to keep servicing high need patients. Our new patient uploads during March were the highest single month since the pandemic began and gave us the ability to grow our core business even with the challenges faced during January and February. We are excited to continue utilizing our new programs along with our traditional sales methods as more healthcare systems open around the country.”
"Despite these major challenges, we still achieved growth in the quarter of 19% over last year's pre-pandemic and pre-ice storm first quarter. We have expanded our coverage area to 45 states and started up 15 new territories by hiring 15 new reps through April. This execution is on pace to hire 60 new reps during the during 2021, which is the goal at the baseline -- which is the goal that this is the baseline to driving our organic growth. We also expanded our Home Sleep Delivered, sleep apnea business into six new areas, which is another new growth initiatives for 2021."
"We are actively recruiting to hire these social workers throughout our 45 state coverage area and through this you had another new offering that will help grow and differentiate our core business for years to come. Perhaps the best news of the quarter, is that the most of the growth was captured in the month of March, our busiest months since COVID-19 for new patients. The spread of the vaccine throughout the country has driven patient security and confidence to see their physician's again. This pent-up demand from the patients needing to address their healthcare concerns has led to facilities opening up their doors to home care clinicians with solutions that help free up hospital beds. For the first time in a year, our core business is showing signs that we will soon be growing at our normal pre-pandemic growth rates. We are encouraged by this new trend, especially since we have so many new offerings to review with physicians and patients in the years ahead. On the acquisition front, we have been exploring multiple data rooms and learning a lot about several companies that could help springboard our patient growth."
"Our strategy is to look for accretive companies that come with strong human resources to help us carry our Viemed initiative forward faster rate. The companies we are evaluating are medium to large sizes and are in areas that we have a geographic coverage gap. Acquisitions have not been part of our strategy in the past, but with the new regulatory stability and our M&A team in place, we will make acquisitions the meaningful part of our expansion in 2021 and beyond. The regulatory landscape has never been more stable since Mike and I founded the business back in 2006."
"We remain perfectly positioned for rapid growth as we expect to come out of the COVID pandemic over the next few months, in existing and new regions. We have developed a plan of opportunities when it comes to inorganic growth and have begun to build out a team to help evaluate and ultimately integrate down the road. Our mission aligns us with many other respected health care companies and remain confident that we'll find something to augment our historically high organic growth rates."